- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00969124
Impact of Experience on Results With the Third Eye Retroscope
Impact of Experience With the Third Eye Retroscope on Detection Rates and Withdrawal Times During Colonoscopy
The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope.
Previous studies have shown that physicians are able to detect additional polyps when they use the device along with the colonoscope. The purpose of this study is to determine whether physicians can detect greater numbers of additional polyps as they gain in experience with the device.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose: This study is intended to determine characteristics of the "learning curve" for use of the Third Eye Retroscope during colonoscopy, both in terms of efficacy for detection of abnormalities in the colon and time-efficiency for endoscopists
Device Description: The Third Eye Retroscope is an auxiliary imaging device that is designed to allow visualization of "hidden areas" during colonoscopy by providing an additional, retrograde view that complements the forward view of the colonoscope.
After a standard colonoscope has been advanced to the cecum, the Third Eye Retroscope is inserted through the instrument channel of the colonoscope. As it emerges from the distal tip of the colonoscope, the Third Eye Retroscope automatically bends 180 degrees to form a "J" shape. Its sensor then provides a continuous retrograde view of the colon throughout the process of withdrawal of the colonoscope.
The retrograde view assists the endoscopist in visualizing the proximal aspect of haustral folds and rectal valves, as well as the areas behind flexures and the ileocecal valve. With this additional point-of-view, the endoscopist may be able to detect lesions that can be missed by the forward-viewing colonoscope.
Study Design: Patients who are scheduled for colonoscopy will be recruited to the study and examined with the Third Eye Retroscope in conjunction with a standard colonoscope. For each polyp that is found, the endoscopist will indicate whether it could be seen with the colonoscope, or if it could be found with the colonoscope only because it was first detected with the Third Eye.
Each investigator will perform colonoscopies on 20 patients, who will be segmented into four quartiles according to the order of their procedures. Mean results for the quartiles will be compared in order to evaluate the learning curve for Third Eye colonoscopy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Celebration, Florida, United States, 34747
- Florida Hospital
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
Evanston, Illinois, United States, 60201
- NorthShore University HealthSystem
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- University of Massachusetts
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
-
Texas
-
Dallas, Texas, United States, 75246
- Baylor University Medical Center
-
Dallas, Texas, United States, 75235
- Parkland Hospital
-
Fort Worth, Texas, United States, 76132
- S.W. Fort Worth Endoscopy Center
-
North Richland Hills, Texas, United States, 76180
- North Hills Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
- The patient must understand and provide written consent for the procedure.
Exclusion Criteria:
- Patients with a history of colonic resection;
- Patients with inflammatory bowel disease;
- Patients with a personal history of polyposis syndrome;
- Patients with suspected chronic stricture potentially precluding complete colonoscopy;
- Patients with diverticulitis or toxic megacolon;
- Patients with a history of radiation therapy to abdomen or pelvis.
- Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Third Eye Retroscope
All subjects underwent the same intervention, consisting of examination of the colon using a colonoscope along with the Third Eye Retroscope device, with removal of any polyps that were detected during the procedure.
|
Third Eye Retroscope is used in conjunction with a standard colonoscope while performing colonoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection Rates for Adenomas
Time Frame: During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
Adenomas detected with the colonoscope alone vs. with the Retroscope
|
During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
|
Detection Rates for All Polyps
Time Frame: During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
All polyps detected with the colonoscope alone vs. with the Retroscope
|
During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time Spent During Withdrawal Phase and Total Procedure
Time Frame: During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
Time in minutes for withdrawal phase of procedure and for total procedure
|
During the colonoscopy procedure (up to 1 hour, average 25 minutes)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel C DeMarco, MD, Baylor Health Care System
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Avantis TER 08-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasms
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
University of ChicagoVerastem, Inc.SuspendedColorectal Cancer | Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Colorectal AdenocarcinomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
ProgenaBiomeWithdrawnColorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal SarcomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Colorectal Adenocarcinoma | Refractory Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Unresectable Colorectal AdenocarcinomaUnited States
-
Endeavor HealthEnrolling by invitationColorectal Cancer | Colorectal Adenoma | Colorectal PolypUnited States
-
Bristol-Myers SquibbNovartisCompletedColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaUnited States, Canada, Spain, Argentina, Australia, Belgium, Czechia, Italy, Chile, Germany
Clinical Trials on Third Eye Retroscope
-
Avantis Medical SystemsCompletedColorectal NeoplasmsNetherlands, United States, Belgium, Italy, United Kingdom
-
M.D. Anderson Cancer CenterAvantis Medical SystemsCompleted
-
Avantis Medical SystemsUnknown
-
Government College University FaisalabadAllied Hospital FaisalabadRecruitingTeletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder (TIPCBT-GAD)Generalized Anxiety DisorderPakistan
-
BayerCompleted
-
Amerigo GiudiceRecruitingTooth Disease | Facial Swelling | Tooth Extraction Status Nos | Tooth Avulsion | Tooth Impacted | Piezoelectric Technique | GermectomyItaly
-
Xiaoliang GanUnknownChild | Anesthesia | AgitationChina
-
Universitaire Ziekenhuizen KU LeuvenCompletedImpacted Third Molar Tooth
-
Universidad Complutense de MadridEnrolling by invitationTrauma, Psychological | Traumatic Stress DisorderSpain
-
Sohag UniversityNot yet recruitingHydrocephalus | Shunt Malfunction